ASBP

Aspire Biopharma Holdings, Inc. Common Stock

15 hedge funds and large institutions have $876K invested in Aspire Biopharma Holdings, Inc. Common Stock in 2025 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
15
Holders Change
+12
Holders Change %
+400%
% of All Funds
0.2%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
13
Increased
1
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Toronto Dominion Bank
1
Toronto Dominion Bank
Ontario, Canada
$350K +$350K +516,845 New
CA
2
Crewe Advisors
Utah
$183K +$183K +313,427 New
HCI
3
Harraden Circle Investments
New York
$87.4K -$175K -299,783 -67%
OAS
4
Optivise Advisory Services
Tennessee
$62K +$62K +106,446 New
PA
5
Procyon Advisors
Connecticut
$57.4K +$57.4K +98,500 New
PC
6
Periscope Capital
Ontario, Canada
$33.8K +$33.8K +75,000 New
PTP
7
Platform Technology Partners
New York
$21.9K +$21.9K +37,611 New
UBS Group
8
UBS Group
Switzerland
$17.5K +$17.4K +29,900 +66,444%
TSS
9
Two Sigma Securities
New York
$16K +$16K +27,413 New
Citadel Advisors
10
Citadel Advisors
Florida
$15.7K +$15.7K +26,901 New
Jane Street
11
Jane Street
New York
$12.2K +$12.2K +21,019 New
VF
12
Virtu Financial
New York
$10K +$10K +16,694 New
Susquehanna International Group
13
Susquehanna International Group
Pennsylvania
$9.34K +$9.34K +16,023 New
RFA
14
Reyes Financial Architecture
California
$82 +$82 +140 New
FFA
15
Farther Finance Advisors
California
$12 +$12 +20 New
CS
16
Clear Street
New York
-$183K -15,891 Closed